Skip to main content
. 2017 Jul 15;22:164–172. doi: 10.1016/j.ebiom.2017.07.013

Table 2.

Baseline characteristics in study 2.

ID
IM
IN
0.0059/0.1 0.059/1 0.59/10 Placebo 0.29/5 Placebo 0.29/5 1.2/20 4.8/80 Placebo
n 4 6 6 6 6 1 4 6 6 7
Age (years) 24.8 (5.1) 30.8 (8.3) 26.5 (6.0) 32.0 (8.4) 34.3 (9.2) 30.0 23.5 (5.7) 30.0 (5.9) 27.7 (5.9) 26.9 (6.8)
Weight (kg) 65.88 (9.18) 72.53 (12.10) 71.77 (6.54) 65.53 (12.57) 65.25 (10.47) 56.20 68.70 (8.46) 71.85 (13.56) 64.62 (18.31) 71.20 (11.38)
Height (cm) 165.0 (6.9) 173.8 (10.4) 172.8 (8.7) 165.5 (5.6) 172.8 (12.4) 165.0 172.5 (3.1) 171.8 (8.4) 165.8 (11.7) 170.9 (10.9)
Sex
 Female 4 (100%) 3 (50%) 2 (33%) 4 (67%) 4 (67%) 1 (100%) 3 (75%) 4 (67%) 4 (67%) 5 (71%)
Race
 Asian 1 (25%) 0 0 2 (33%) 0 0 0 0 1 (17%) 0
Black or African American 0 0 0 0 1 (17%) 0 0 2 (33%) 0 1 (14%)
Other 0 0 1 (17%) 0 0 0 0 0 0 0
White 3 (75%) 6 (100%) 5 (83%) 4 (67%) 5 (83%) 1 (100%) 4 (100%) 4 (67%) 5 (83%) 6 (86%)

Data are mean (SD) or n (%), unless otherwise indicated. Vaccine groups are quantified as per μg of OAg/μg of protein. ID = intradermal. IN = intranasal. IM = intramuscular.